Visualisation of a Digital Care Pathway.
1 other identifier
interventional
45
1 country
1
Brief Summary
As part of the EFRO (Europees Fonds Regionale Ontwikkeling) 1302 project "Digital Care Support in Practice with Limburg as a Stepping Stone for Flanders", this study aims to evaluate the concept and added value of visualising a personal digital care pathway for patients with type 2 diabetes. Firstly, this chronological visualisation of data strives to improve patient experience and empowerment by offering educational articles and personal medical data relevant to their care path in one place. This way, patients will have more insight in the pathogenesis, treatments, complications and goals, allowing the patients to optimize their selfcare and become confident in dealing with their chronic condition. From time to time, patients will also be asked to complete questionnaires concerning their experiences (PREM) to aid healthcare professionals in personalizing treatment goals. Secondly, the healthcare providers and caregivers surrounding the patient will also have access to the same data, allowing for a more personal approach as well as means to communicate with other members of the care team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes
Started Oct 2021
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 27, 2021
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFebruary 24, 2022
January 1, 2022
5 months
October 27, 2021
February 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in patient empowerment and involvement
Primary outcome measures will be determined with the aid of a questionnaire scoring answers on a 5p-Likert scale. Due to limited availability of validated questionnaires in Dutch, a custom set of questions was generated. Starting from validated English questionnaires on each topic, the Delphi method was used to reach consensus in selecting the final questions. At the end of the study, an in-depth interview will take place with a predefined topic list.
For a minimum of 12 weeks
Change in care team communication and sharing of data
Primary outcome measures will be determined with the aid of a questionnaire scoring answers on a 5p-Likert scale. Due to limited availability of validated questionnaires in Dutch, a custom set of questions was generated. Starting from validated English questionnaires on each topic, the Delphi method was used to reach consensus in selecting the final questions. At the end of the study, an in-depth interview will take place with a predefined topic list.
For a minimum of 12 weeks
Usability and acceptance of the application in patients and healthcare professionals
Primary outcome measures will be determined with the aid of a questionnaire scoring answers on a 5p-Likert scale. Due to limited availability of validated questionnaires in Dutch, a custom set of questions was generated. Starting from validated English questionnaires on each topic, the Delphi method was used to reach consensus in selecting the final questions. At the end of the study, an in-depth interview will take place with a predefined topic list.
For a minimum of 12 weeks
Secondary Outcomes (6)
User characteristics of the application.
for a minimum of 12 weeks
Possible change,impact on personal clinical parameters: HbA1c
for a minimum of 12 weeks
Possible change,impact on personal clinical parameters: blood pressure
For a minimum of 12 weeks
Possible change,impact on personal clinical parameters: glycemia
For a minimum of 12 weeks
Possible change,impact on personal clinical parameters: girth
For a minimum of 12 weeks
- +1 more secondary outcomes
Study Arms (2)
patients
EXPERIMENTALImplementation and visualisation of digital care path. Pre measurement: questionnaire quantifying patient involvement and experience on a 5-p Likert scale. Post measurement: questionnaire quantifying patient involvement and experience on a 5-p Likert scale, questionnaire quantifying usability of the tool and in-depth interview.
healthcare professionals
EXPERIMENTALImplementation and visualisation of digital care path. Pre measurement: questionnaire quantifying communication needs and experiences on a 5-p Likert scale. Post measurement: questionnaire quantifying communication needs and experiences on a 5-p Likert scale, questionnaire quantifying usability of the tool and in-depth interview.
Interventions
The implementation and visualisation of a digital care path, specifically designed for patients with type 2 diabetes and their care team. The digital care path wil include: 1) a timeline with appointments, messages and questionnaires 2) Diabetes related articles 3) a page for monitoring clinical parameters and goals 4) a section displaying information on their care team and personal health records. The aim of this intervention is to evaluate whether providing a central platform for all data will increase patient empowerment and involvement. Secondly it will also evaluate whether the communication between healthcare professionals improves when selected data is readily available for the entire care team.
Eligibility Criteria
You may qualify if:
- patients with type 2 diabetes (voortraject and zorgtraject)
- independent and mentally competent
- digitally literate and in possession of an email address
- mastered the Dutch language
- able to visit the GP (no house calls)
- presence of a home nurse in the context of the Diabetes care
- presence of a home care service
You may not qualify if:
- patients type 2 Diabetes enrolled in the Diabetes convention
- pregnant patients
- illiterate people
- patients living in a residential care center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
- Wit-Gele Kruis Limburgcollaborator
- KLAVcollaborator
- Ferm Thuiszorgcollaborator
- I-menscollaborator
- Vlaams Patiëntenplatformcollaborator
- Wit-Gele Kruis Vlaanderencollaborator
- POM Limburgcollaborator
Study Sites (1)
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yves Breysem, Dr
Jessa Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2021
First Posted
February 7, 2022
Study Start
October 1, 2021
Primary Completion
February 28, 2022
Study Completion
June 30, 2022
Last Updated
February 24, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share